Intradermal Delivery of Alopecia Therapeutics: Current State and Future Prospects

Dermatol Surg. 2023 Sep 1;49(9):851-854. doi: 10.1097/DSS.0000000000003866. Epub 2023 Jun 22.

Abstract

Background: Mesotherapy, a technique of transdermal microinjections of specific preparations, is increasingly used in fields such as dermatology and specifically for alopecia treatment. Its popularity stems from its ability to deliver drugs in a targeted manner while minimizing systemic side effects.

Objective: To assess and review current knowledge regarding the use of mesotherapy to deliver alopecia medications and highlight future directions for research.

Materials and methods: The authors used research databases including PubMed and Google Scholar to identify current literature on mesotherapy and alopecia. The following search terms were used among other terms: "Mesotherapy" or "Intradermal" AND "Alopecia".

Results: Recent studies are promising for the intradermal delivery of dutasteride and minoxidil in the treatment of androgenetic alopecia.

Conclusion: Although limitations exist with dutasteride and minoxidil therapies, further research regarding the preparation, delivery, and maintenance of these drugs is warranted as mesotherapy could establish this technique as a safe, effective, and viable treatment option for androgenetic alopecia.

MeSH terms

  • Alopecia / drug therapy
  • Drug-Related Side Effects and Adverse Reactions*
  • Dutasteride / therapeutic use
  • Humans
  • Mesotherapy*
  • Minoxidil / therapeutic use
  • Treatment Outcome

Substances

  • Dutasteride
  • Minoxidil